Artiva Biotherapeutics to Lay Off About 94% of Workforce
Artiva Biotherapeutics is laying off about 94% of its workforce after a drug trial failure and two patient deaths.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.